Retina/Vitreous News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses the company’s shift to a retina-focused program.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jordi Monés, MD, PhD, discusses an investigational optogenetic therapy for geographic atrophy.

The FDA has extended its Prescription Drug User Fee Act date for the biologics license application for NT-501, a treatment for macular telangiectasia type 2, according to a press release from Neurotech Pharmaceuticals.

BARCELONA, Spain – In this Healio Video Perspective from the Euretina congress, Tien Yin Wong, MD, shares his thoughts on the emerging role of AI in retina.

Patients who reside in socioeconomically deprived neighborhoods have a higher chance to present with more severe rhegmatogenous retinal detachment, according to a study.

BARCELONA, Spain – In this Healio Video Perspective at the Euretina congress, Baruch D. Kuppermann, MD, PhD, delivers an overview of new compounds currently under investigation for dry age-related macular degeneration.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Sundaram Natarajan, MD, shares his experience with wide-angle viewing systems.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Michael W. Stewart, MD, shares his experience with Eylea HD in neovascular age-related macular degeneration and diabetic macular edema.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Sujay Jadhav, CEO of Verana Health, discusses two of the company’s new data collection modules which launched during the AAO meeting.

The FDA granted de novo marketing authorization Valeda Light Delivery System for the treatment of dry age-related macular degeneration, according to a press release from LumiThera.